SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-244689
Filing Date
2021-08-12
Accepted
2021-08-12 16:13:22
Documents
54
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d190507d10q.htm   iXBRL 10-Q 1272137
2 EX-31.1 d190507dex311.htm EX-31.1 6600
3 EX-31.2 d190507dex312.htm EX-31.2 6663
4 EX-32.1 d190507dex321.htm EX-32.1 3164
5 EX-32.2 d190507dex322.htm EX-32.2 3156
  Complete submission text file 0001193125-21-244689.txt   4174465

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA vinc-20210630.xsd EX-101.SCH 27753
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vinc-20210630_cal.xml EX-101.CAL 26688
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vinc-20210630_def.xml EX-101.DEF 114644
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE vinc-20210630_lab.xml EX-101.LAB 262302
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vinc-20210630_pre.xml EX-101.PRE 207487
11 EXTRACTED XBRL INSTANCE DOCUMENT d190507d10q_htm.xml XML 483780
Mailing Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306
Business Address 260 SHERIDAN AVENUE SUITE 400 PALO ALTO CA 94306 650-800-6676
Vincerx Pharma, Inc. (Filer) CIK: 0001796129 (see all company filings)

IRS No.: 833197402 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39244 | Film No.: 211167694
SIC: 2834 Pharmaceutical Preparations